By fitting dynamic contrast-enhanced MRI data to an appropriate pharmacokinetic model, quantitative physiological parameters can be estimated. In this study, we compare four different models by applying four statistical measures to assess their ability to describe dynamic contrast-enhanced MRI data obtained in 28 human breast cancer patient sets: the chi-square test (x 2 ), Durbin-Watson statistic, Akaike information criterion, and Bayesian information criterion. The pharmacokinetic models include the fast exchange limit model with (FXL_v p ) and without (FXL) a plasma component, and the fast and slow exchange regime models (FXR and SXR, respectively). The results show that the FXL_v p and FXR models yielded the smallest x 2 in 45.64 and 47.53% of the voxels, respectively; they also had the smallest number of voxels showing serial correlation with 0.71 and 2.33%, respectively. The Akaike information criterion indicated that the FXL_v p and FXR models were preferred in 42.84 and 46.59% of the voxels, respectively. The Bayesian information criterion also indicated the FXL_v p and FXR models were preferred in 39.39 and 45.25% of the voxels, respectively. Thus, these four metrics indicate that the FXL_v p and the FXR models provide the most complete statistical description of dynamic contrast-enhanced MRI time courses for the patients selected in this study. Magn Reson Med 68:261-271,
Dynamic contrast-enhanced MRI (DCE-MRI) involves the acquisition of images before and after an intravenous injection of contrast agent (CA). By fitting DCE-MRI data to a pharmacokinetic model, quantitative physiological parameters such as the volume transfer constant (K trans ), extravascular-extracellular volume fraction (v e ), and the plasma fraction (v p ) can be estimated (1) (2) (3) . In diagnosing breast cancer, DCE-MRI has shown high sensitivity (77-100%) but moderate specificity (26-97%) ((4-8), reviewed in Ref. 9) . In monitoring treatment response in breast cancer, there have been many efforts using DCE-MRI as a surrogate biomarker for predicting response to neoadjuvant chemotherapy. Several investigators have proposed both semiquantitative and quantitative methods for classifying contrast enhancement curves and have used this information to delineate complete response from partial response and progressive disease (see, e.g., Refs. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . For example, some investigators have shown that changes in tumor size as measured by dynamic MRI significantly correlate with residual disease at time of surgery (e.g., Refs. [10] [11] [12] [13] . Considering the potentially more difficult question of predicting treatment response early in the course of therapy, some investigators have shown that changes in tumor volume as measured by dynamic MRI after one cycle of therapy significantly correlate with pathologic response (e.g., Refs. 14 and 15). Morphological characteristics (such as tumor size) are the downstream effects of underlying physiological changes, so it seems reasonable that changes in metrics of tumor perfusion could serve as biomarkers of early response to treatment.
However, the literature presents differing results regarding the predictive value of quantitative modeling of DCE-MRI data; some have shown that kinetic analysis was not predictive after early therapy (15, 21) , whereas others have shown that it is (14, 22) . These contradictory results may not be surprising considering the significant differences in tumor type, treatment regimen, number of patients, clinical and pathological endpoints, imaging data acquisition, and data analysis techniques. Another possible reason for such apparent discrepancies is that the standard DCE-MRI model used to analyze such data may not adequately describe the relevant physiology. The standard model relies on a linear dependence between the measured longitudinal relaxation rate constant R 1 (:1/T 1 ) and the concentration of CA in tissue (23, 24) . This model assumes that tissue is effectively one well-mixed compartment of water; in MRI, this assumption is referred to as the fast exchange limit (FXL). Several studies have presented evidence that this assumption is violated in vivo especially when the concentration of CA in the voxel of interest is high, and efforts have been made to develop analyses that do not make this assumption (23) (24) (25) (26) (27) (28) (29) . By considering the extravascular space as two separate compartments, an extravascular-extracellular space and an extravascular-intracellular space, models can be built that account for the limited rate of water exchange between these compartments. This ''fast exchange regime'' (FXR) model has revealed that significant errors may arise when using the FXL analysis (24) . In particular, initial applications of the FXR model to human breast cancer DCE-MRI data suggest that the FXL formalism used in these studies can grossly underestimate blood flow, vessel wall permeability, and extravascularextracellular volume fractions (27) (28) (29) .
Although a few of studies have performed comparisons of kinetic models for DCE-MRI data of the prostate or cervix (30, 31) , none has been performed for breast cancer. Here, we report the results of standard statistical tests on the breast cancer DCE-MRI analyses provided by the FXL with and without a vascular term and the fast and slow exchange regime models (FXR and SXR, respectively) to assess which model is most robust in a statistical sense. Because DCE-MRI ultimately aims to positively impact clinical diagnosis and prediction of treatment response, the choice of model to perform the analysis is of central importance.
MATERIALS AND METHODS

Data Acquisition
Fifteen patients with locally advanced breast cancer were enrolled in an ongoing clinical trial (32) . The patients provided informed consent, and the study was approved by the ethics committee of the Vanderbilt-Ingram Cancer Center. DCE-MRI was performed using a Philips 3T Achieva MR scanner (Philips Healthcare, Best, The Netherlands). A four-channel receive double-breast coil covering both breasts was used for all imaging (Invivo Inc., Gainesville, FL). Data for constructing a T 1 map were acquired with an radiofrequency-spoiled three-dimensional gradient echo multiflip angle approach with TR ¼ 7.9 ms, TE ¼ 1.3 ms, and 10 flip angles from 2 to 20 in 2 increments. The acquisition matrix was 192 Â 192 Â 20 (full-breast) over a sagittal square field of view (22 cm 2 ) with slice thickness of 5 mm, one signal acquisition, and a sensitivity encoding (SENSE) factor of 2 for an acquisition time of just under 3 min. The dynamic scans used identical parameters and a flip angle of 20 . Each 20-slice set was collected in 16 s at 25 time points for $7 min of scanning. A catheter placed within an antecubital vein delivered 0.1 mmol/kg (9-15 mL) of the CA gadopentetate dimeglumine, Gd-diethylenetriamine penta-acetic acid (DTPA) (Magnevist, Wayne, NJ) at 2 mL/s (followed by a saline flush) via a power injector after the acquisition of three baseline dynamic scans for the DCE study. Four patients were scanned at three time points: pretreatment, after one cycle of neoadjuvant chemotherapy, and after all cycles of chemotherapy; and the other 11 patients were scanned at the first two time points, yielding a total of 34 data sets. Six out of the 34 data sets failed to characterize the first pass or wash-out features of the arterial input function (AIF), yielding a total of 28 useable data sets.
Theory
The measured signal intensity from a spoiled gradient echo acquisition can be described by Eq. 1:
where a is the flip angle, TR is the repetition time of the excitation radiofrequency pulse of the MR imaging sequence, S 0 is a constant describing the scanner gain and proton density, and we have assumed that TE ( T 2 *. To perform quantitative DCE-MRI data analysis, the timevarying longitudinal relaxation time, T 1 (t), must be related to the concentration of CA in the tissue, C t (t). Usually, a linear relationship between the two quantities is assumed:
where R 10 is the R 1 value of the tissue before CA administration and r 1 is the relaxivity of the CA. In actual DCE-MRI experiments, the C t time course cannot be directly measured, and thus Eq. 2 needs to be expressed in terms of the quantities that are actually measurable in an MRI experiment (i.e., the relaxation rate constants). Toward this end, we use the Kety relationship (33): where K trans is the CA extravasation rate constant, v e is the extravascular-extracellular volume fraction, and C p (t) is the concentration of CA in blood plasma, also known as the AIF. In this study, a semiautomatic AIF tracking algorithm is used to calculate the AIF for each patient. This algorithm is initialized by defining a kernel centered on a manually selected seed point within the axillary artery in one slice. In an adjacent slice, the center of the artery is detected through searching the maximum Pearson correlation coefficient (CC) of the signal intensity between the kernel and the region of interests in the adjacent slice. The procedure is repeated for all slices to find all voxels within the artery that are then used to construct an AIF; more details are provided in Ref. 34 .
A more complex model incorporates the blood plasma volume fraction, v p :
½4
Substituting Eqs. 3 and 4 into 2 yields Eqs. 5 and 6, respectively:
½6
Equations 5 and 6 are two of four models we assess in the study, which are termed the FXL and FXL_v p , respectively.
The ''fast exchange'' limit relationship described above is equivalent to assuming that all water compartments within the tissue are well mixed so the effects of the CA are completely described by a single rate constant. However, tissue is not homogeneous, but rather it may be compartmentalized within an MRI voxel. The use of Eq. 2 for the entire 1 H 2 O signal from a voxel requires that water exchange between the vascular, extravascular-intracellular space, and the extravascular-extracellular spaces are sufficiently fast. In practice, this is often not the case; and, when it is not, the Bloch equations should incorporate the effects of this exchange, leading to longitudinal relaxation that can be characterized by biexponential decay:
where
T 1S and T 1L are the apparent shorter and longer T 1 components, respectively, R 1i is the intracellular R 1 , t i is the average intracellular water lifetime of a water molecule, and f w is the fraction of water that is accessible to mobile CA (23) (24) (25) , which is set to 1.0 in this study. Equation 9 with and without the T 1S yields the other two models that we evaluate, which are termed the FXR and SXR models, respectively (24) .
Statistical Analysis
We used four common statistical tests to assess the analyses provided by Eqs. 5, 6, and 9. The first is the Durbin-Watson (D-W) statistic that is a commonly used test for detecting serial correlation in residuals (35) and is computed via Eq. 10:
where e i are the residuals. In regression analysis, errors are typically assumed to be pairwise uncorrelated; serial correlation is a special case in which correlations between errors separated by i steps are similar (35) . If residuals exhibit positive serial correlation, successive residuals tend to be similar, whereas in negative serial correlation, the successive residuals are dissimilar. 
The second statistical test applied to the models is the standard chi-square test, x 2 , which is given as Eq. 11:
where y fit is the estimated value of the actual data, y i , and n o is the number of degrees of freedom. The third statistical test used to determine the validity of the models is the Akaike information criterion (AIC). Given a set of models, the AIC is a method to select the model that best balances goodness of fit with number of free parameters (36) . It is computed via Eq. 12:
where n is the number of observations, k is the number of parameters, and RSS is the residual sum of squares. Note that Eq. 12 is the form of the AIC that includes a second-order correction to account for a small number of observations; this is typically denoted by the subscript ''c'' on ''AIC.'' In the experimental data presented below, there are 25 observations in the DCE time series data and the FXL model has two free parameters, whereas the FXL_v p , FXR, and SXR models each have three free parameters. The model returning the lowest AIC c value is the model that represents the best balance between complexity (i.e., the number of free parameters) and goodness of fit (i.e., lower RSS). The fourth and final statistical test we used is the Bayesian information criterion (BIC), which is also used to detect the balance between the goodness of fit and the model complexity. AIC c and BIC measure a model similarly, except that the BIC applies a heavier penalty on the model complexity:
Data Analysis
Precontrast T 1 values, T 10 values were computed by fitting the multiflip angle data to Eq. 1. Voxels for which Eq. 1 could not fit the data were set to zero and not included in the analysis. Data from each DCE-MRI study were fit on a voxel-by-voxel basis with Eqs. 5, 6, and 9 to yield estimates of K trans (all models), v e (all models), v p (FXL_v p model only), and t i (FXR and SXR only). The fitting routine uses a standard gradient-expansion, nonlinear, least-square, curve-fitting algorithm written in the Interactive Data Language (RSI, Boulder, CO).
Implicit in this analysis is the requirement for measuring or estimating the AIF. We have proposed a simple and efficient method (34) to obtain the AIF, through tracking an initial seed point placed within the axillary artery. Using this method, we obtain the AIF for each individual patient. Voxels for which the fitting algorithm did not converge, or converged to unphysical values (e.g., K trans > 5.0 min À1 , v e > 1, v p > 1, t i > 3.0 s, or any parameter below zero) were set equal to zero. Along with the parameter estimates, values for D-W, x 2 , AIC c , and BIC statistics were also saved for each voxel. Voxels were defined as ''enhancing'' if the averaged postcontrast signal intensities increased by 50% over the average signal intensity precontrast time points. Figure 1 shows an example of the model fit to the experimental data for one enhancing tumor pixel. For this data, the mean absolute differences between the experimental data and the fit data returned by FXL, FXL with v p , FXR, and SXR are 0.0044, 0.0022, 0.0019, and 0.0034, respectively. (Please note that the ''waviness'' in the fit curve is due to the noise present in the individually measured AIF; that is, a smoothed AIF would result in a smoothed fit.) Figure 2 shows an example of K trans parametric maps returned by the four models; from left to right, the maps were obtained from the FXL, FXL_v p , FXR, and SXR, respectively. The AIF obtained from this patient by our method (34) is also shown in the figure. Observe how the SXR model cannot estimate the K trans values for most of the tumor voxels; the SXR model could converge on only 35 6 15% of the enhancing tumor voxels, whereas the FXL, FXL_v p , and FXR models can converge on 74 6 17, 56 6 16, and 72 6 16% of the enhancing voxels, respectively. As we need to compare all models involved for each voxel, if we examine the voxels only for which the SXR returns an accurate fit, this greatly reduces the number of data points available for comparison. For this reason, we did
RESULTS
1. An example of the plots of the fit and experimental data. Please note that the ''waviness'' in the fit curve is due to the noise in the individually measured AIF; when the AIF is smoothed, the waviness is eliminated.
FIG. 2. An example of the K
trans values returned by the four models; from left to right, the maps are given by FXL, FXL_v p , FXR, and SXR models. The AIF obtained from this patient (by our previously proposed method) is also shown on the right. It is clear that model selection can greatly affect the parameter values that are returned, and this is why it is necessary to develop a method to select which model is most appropriate.
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not continue the analysis with the SXR model; and hereafter, we focus on the remaining three models. We return to this point in the ''Discussion'' section. 
Comparison of DCE-MRI Models in Breast Cancer
values in all data sets and FXL returned the smallest median v e values in 75% data sets. These results match those reported elsewhere in the literature (24) (25) (26) .
The percentage of voxels with serial correlation is presented in Fig. 6 . The FXL_v p and FXR models result in 0.71 and 2.33% voxels with serial correlation respectively, indicating a substantially superior description of the time courses relative to the FXL model, which displayed serial correlation in 17.64% of the voxels. Figure , respectively. The average signal-to-noise ratio for the tumor region of interests from the central slice is 14.0 6 6.5; because these are SENSE accelerated scans, the signal-to-noise ratio was computed as the mean of two precontrast scans multiplied by ffiffiffi 2 p and divided by the standard deviation of the difference between those two scans (37) . Table 1 
between the FXL and FXL_v p and between the FXL and FXR are less than 0.005 in all statistical metrics, whereas there is no significant difference between the FXL_v p and FXR models according to the AIC and BIC metrics. These model differences can lead to differences in the actual pharmacokinetic parameter values. The mean parameter values for all tumor voxels of each data set are given in Table 2 The mean CC for all data sets is given in Table 3 . The results show that the correlation between K trans returned by the FXL and FXL with v p models is the strongest (CC ¼ 0.89), whereas the correlation between K trans returned by the FXL with v p model and the FXR model is the weakest (CC ¼ 0.51). The correlations between v e returned by different models are similar (from 0.51 to 0.58).
DISCUSSION
The physiological parameters K trans and v e are measured in practice to both diagnose and assess treatment response in breast cancer (4-9,38), but their values estimated by DCE-MRI analysis are often strongly influenced by which model is selected. We have attempted to offer evidence that the FXL model with a plasma component (Eq. 6) and the FXR model (Eq. 9) are both statistically superior to the FXL model (Eq. 5) in the analysis of human breast cancer DCE time courses. Furthermore, the three models return statistically significantly different K trans and v e values. Although the FXR model has been argued on physical and physiological grounds (23, 24) , the question of which model is statistically superior in human breast cancer has not been previously established. Experiments in this study show that the D-W, chi-square, AIC, and BIC all favor the use of either the FXL with the v p component (FXL_v p ) or the FXR approach for the patient group used in this study.
Unfortunately, for our data sets, the SXR model was unable to converge on most of the enhancing tumor voxels. One possible reason is that this model calculates both T 1L and T 1S in Eqs. 7-9, making the fitting procedure more complicated. This severely limited our ability to compare this model to the others. It could be that the limited signal-to-noise ratio available in our breast DCE-MRI acquisitions (where we have tried to balance spatial and temporal resolution requirements) is not sufficient to allow for analysis with this model. Future studies will investigate this point.
A natural extension to the FXR, for which there is physiological motivation, is to add a blood volume component. Unfortunately, adding a blood compartment and still accounting for water exchange between all the Table 1 . (43) (44) (45) . For instance, the work of Li et al. (43) reported that the mean K trans and v e (obtained from a FXL analysis) at baseline in breast cancer were 0.33 min À1 and 0.44, respectively. In the effort of Li et al. (44) , the mean K (45) also showed that the median K trans of baseline for the patients with metastatic breast cancer ranged from 0.65 to 1.7 min À1 . One possible reason for the higher values in K trans and v e is the limitation of the models for tumors with the extreme spatial heterogeneity. For example, in regions that are poorly perfused the CA will accumulate and wash out slowly, which can lead to large values in v e . For example, Jansen et al. (46) found that the CA could accumulate within the milk ducts filled with ductal carcinoma in situ. Under this situation, the models investigated in this study will not be able to accurately estimate the extravascular-extracellular volume. Another source of possible error could be in the measured AIF. The inaccuracy in the AIF could cause the propagation of errors in the estimated parameters. The temporal resolution of 16 s used in this study is not optimal for AIF characterization (although it is reasonable as it represents a compromise between high temporal resolution and large spatial coverage), and it may miss the peak of AIF and therefore cause larger values of parameters, particularly K trans . Also, direct measurements from the artery are likely to underestimate the peak amplitude of the AIF due to T 2 * and exchange effects. Those factors affect the accuracy of the AIF, and consequently, affect the measurements of the pharmacokinetic parameters.
Use of the FXL with a plasma fraction and the FXR model resulted in a substantial reduction in percentage of voxels showing positive serial correlation of residuals: 17.64, 0.71, and 2.33% for the FXL, FXL_v p , and FXR models, respectively. In 47.53% of voxels, the x 2 indicated that the FXR model was superior, and in 46.59 and 45.25% of voxels, the AIC c and BIC also indicated that the FXR model was superior. This translated into significant differences in the values of K trans and v e that were extracted in the voxel-by-voxel analyses, and underscores the fact that different models can yield different pharmacokinetic parameter values. It is therefore of great importance to select the appropriate model to analyze the DCE-MRI time courses so that the most accurate parameter estimates are obtained. It is plausible that inappropriate model selection can lead to inaccuracy in, for example, predicting treatment response. It was the overall goal of this study to provide a reasonable rationale for model selection. Although the results presented do not provide a physical or physiological basis for selecting a particular model, they do provide an objective statistical basis for selecting a particular model. In general, the applicability of each model, as well as other It is difficult to know, a priori, the underlying physiological characteristics of a given voxel of breast tissue, so it is difficult to select which model is most realistic. In this case, a statistical assessment of model fitting is not only a reasonable way to proceed but also practical because it provides a rigorous reason for selecting a given model over another. Furthermore, the statistical results can reflect some of the underlying physiological properties of a given breast tumor. For example, in cases where the FXL_v p model is selected by the statistical measures as the most accurate, we can infer that those voxels have a significant plasma component (i.e., v p > $0.03), whereas in those situations where the FXR model is selected, we can infer that the difference in concentration of CA between the extravascular-extracellular space and the extravascular-intracellular space must be great enough to drive the system out of the FXL. The ultimate test for these models is their ability to answer important clinical questions, such as treatment effects during longitudinal studies of patients undergoing neoadjuvant chemotherapy or the ability to distinguish malignant breast tumors from benign lesions. Li et al. (29) have performed preliminary analyses on benign and malignant breast diseases. We have an ongoing study testing the abilities of parameters returned by different models to predict the response of breast tumors to neoadjuvant chemotherapy (47) .
In conclusion, the results of the four statistical metrics used in this study indicate that, for the group of patients selected for this study, the FXL with a plasma component and the FXR model have significant advantages over the FXL and SXR models. The methods outlined here also provide a statistical mechanism for selecting and assessing other DCE models. Moreover, our results highlight the possibility that in heterogeneous tissues, the most appropriate models may vary between voxels.
